Mathilde Gavillet

Lausanne, VD 1011, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Initial management of immune thrombocytopenia

Initial management of immune thrombocytopenia

Journal: Revue medicale suisse

Published: September 02, 2026

Evaluation of hyperferitinemia

Evaluation of hyperferitinemia

Journal: Revue medicale suisse

Published: June 26, 2026

Plasma heme pool compartmentalization is linked to pathophysiology in Sickle Cell Disease.

Plasma heme pool compartmentalization is linked to pathophysiology in Sickle Cell Disease.

Journal: PloS one

Published: November 19, 2025

Immune tolerance breakdown in pregnancy: transplantation parallels in chronic intervillositis and villitis of unknown etiology.

Immune tolerance breakdown in pregnancy: transplantation parallels in chronic intervillositis and villitis of unknown etiology.

Journal: American journal of obstetrics and gynecology

Published: November 12, 2025

Obstetrical Impact of Anti-MUT (Anti-MNS35) Alloimmunization.

Obstetrical Impact of Anti-MUT (Anti-MNS35) Alloimmunization.

Journal: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

Published: September 29, 2025

Case Report: A novel approach to prevent chronic histiocytic intervillositis and recurrent pregnancy loss by targeting maternal alloimmunity.

Case Report: A novel approach to prevent chronic histiocytic intervillositis and recurrent pregnancy loss by targeting maternal alloimmunity.

Journal: Frontiers in immunology

Published: August 26, 2025

Alternative 5-Azacitidine 5-Day 100 mg/m2 Dosage Shows Non-Inferiority to Classical Schedule for Myelodysplastic Neoplasm (MDS) and Chronic Myelomonocytic Leukaemia (CMML) Treatment.

Alternative 5-Azacitidine 5-Day 100 mg/m2 Dosage Shows Non-Inferiority to Classical Schedule for Myelodysplastic Neoplasm (MDS) and Chronic Myelomonocytic Leukaemia (CMML) Treatment.

Journal: EJHaem

Published: August 04, 2025

A Novel Heterozygous Mutation in FGB (c.1231_1232 del GA) Causing Hypofibrinogenemia With Mild Bleeding in a Large Swiss family.

A Novel Heterozygous Mutation in FGB (c.1231_1232 del GA) Causing Hypofibrinogenemia With Mild Bleeding in a Large Swiss family.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: March 19, 2025

Epidemiology, Risk Factors, and Outcomes of Neutropenic Enterocolitis in Onco-Hematological Patients According to Chemotherapy Regimen.

Epidemiology, Risk Factors, and Outcomes of Neutropenic Enterocolitis in Onco-Hematological Patients According to Chemotherapy Regimen.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: January 08, 2025

Indications and contraindications to platelet-rich plasma injections in musculoskeletal diseases in case of infectious, oncological and haematological comorbidities: A 2025 formal consensus from the GRIIP (International Research Group on Platelet Injections).

Indications and contraindications to platelet-rich plasma injections in musculoskeletal diseases in case of infectious, oncological and haematological comorbidities: A 2025 formal consensus from the GRIIP (International Research Group on Platelet Injections).

Journal: Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA

Published: January 07, 2025

Sickle cell crisis: inpatient management

Sickle cell crisis: inpatient management

Journal: Revue medicale suisse

Published: November 21, 2024

Neonatal Fc receptor : role and implications in maternal fetal medicine

Neonatal Fc receptor : role and implications in maternal fetal medicine

Journal: Revue medicale suisse

Published: October 21, 2024

Showing 1-12 of 42

Last Updated: 09/26/2026